More importantly, only a gradual increase of p-ERK1/2 expression was observed beginning in normal endometrium and continuing through atypical endometrial hyperplasia to endometrial adenocarcinoma. The gene discussed is MAPK3; the disease is atypical endometrial hyperplasia.